Filtered By:
Condition: Hypertension
Drug: Beta-Blockers
Education: Study
This page shows you your search results in order of relevance. This is page number 15.
Order by Relevance | Date
Total 217 results found since Jan 2013.
Impact of age on characteristics, performance measures and outcomes of inpatients for heart failure in Beijing, China
ConclusionsHF patients aged ≥75 years had distinct clinical profiles, received worse in-hospital therapies and experienced higher in-hospital and 1 year mortality.
Source: ESC Heart Failure - August 2, 2023 Category: Cardiology Authors: Cong Yuan,
Liu He,
Xin Du,
Chao Jiang,
Shi ‐Jun Xia,
Xin Zhao,
Song‐Nan Li,
Cai‐Hua Sang,
De‐Yong Long,
Jian‐Zeng Dong,
Chang‐Sheng Ma Tags: Original Article Source Type: research
Differential Cardiovascular Outcomes of Each Antihypertensive Drug Class in Patients With Hypertension and Breast Cancer Undergoing Doxorubicin-Containing Chemotherapy
CONCLUSION: RAS inhibitors are preferred for the treating hypertension and improving CV outcomes in patients with hypertension and breast cancer undergoing DOX-containing chemotherapy, particularly in patients with comorbid diabetes. However, CCBs are equivalent to RAS inhibitors and are more favorable than BBs and TDs in terms of improving CV outcomes.PMID:37704380 | DOI:10.4048/jbc.2023.26.e34
Source: Journal of Breast Cancer - September 13, 2023 Category: Cancer & Oncology Authors: Hui-Jeong Hwang Sang-Ah Han Source Type: research
